Is BVXV or DGRO a better dividend investment in 2026?

BVXV currently yields 147.06% with a 5% 5-year dividend growth rate. DGRO yields 2.13% with 9.5% growth. The better choice depends on your goal: BVXV offers higher current income.

What is the dividend yield difference between BVXV and DGRO?

BVXV has a forward dividend yield of 147.06% ($2.00/share annually). DGRO yields 2.13% ($1.47/share annually). The yield gap is 144.93 percentage points.

Home › Compare › BVXV vs DGRO

BVXV vs DGRO: Dividend Comparison 2026

BVXV yields 147.06% · DGRO yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BVXV wins by $22.57M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BVXV

● Live price

147.06%

Share price

$1.36

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.60M

Annual income

$9,667,205.19

Full BVXV calculator →

DGRO

iShares Core Dividend Growth ETF

● Live price

2.13%

Share price

$68.98

Annual div

$1.47

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.6K

Annual income

$239.96

Full DGRO calculator →

Portfolio growth — BVXV vs DGRO

📍 BVXV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BVXV	DGRO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BVXV + DGRO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BVXV pays

DGRO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVXV

Annual income on $10K today (after 15% tax)

$12,500.00/yr

After 10yr DRIP, annual income (after tax)

$8,217,124.41/yr

DGRO

Annual income on $10K today (after 15% tax)

$181.24/yr

After 10yr DRIP, annual income (after tax)

$203.97/yr

At 15% tax rate, BVXV beats the other by $8,216,920.45/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVXV + DGRO for your $10,000?

BVXV: 50%DGRO: 50%

100% DGRO50/50100% BVXV

Portfolio after 10yr

$11.32M

Annual income

$4,833,722.57/yr

Blended yield

42.72%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVXV buys

DGRO buys

No recent congressional trades found for BVXV or DGRO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBVXVDGRO

Forward yield	147.06% ✓	2.13%
Annual dividend / share	$2.00 ✓	$1.47
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$22.60M	$31.6K ✓
Annual income after 10y	$9,667,205.19 ✓	$239.96
Total dividends collected	$20.88M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BVXV vs DGRO ($10,000, DRIP)

Year	BVXV Portfolio	BVXV Income/yr	DGRO Portfolio	DGRO Income/yr	Gap
1← crossover	$25,406	$14,705.88	$11,293	$213.22	+$14.1K → BVXV
2	$62,102	$34,917.38	$12,730	$217.32	+$49.4K → BVXV
3	$146,216	$79,767.65	$14,326	$221.10	+$131.9K → BVXV
4	$331,975	$175,523.78	$16,098	$224.56	+$315.9K → BVXV
5	$727,658	$372,444.73	$18,064	$227.74	+$709.6K → BVXV
6	$1,541,551	$762,956.42	$20,246	$230.65	+$1.52M → BVXV
7	$3,160,048	$1,510,588.88	$22,666	$233.30	+$3.14M → BVXV
8	$6,275,251	$2,893,998.93	$25,349	$235.73	+$6.25M → BVXV
9	$12,085,478	$5,370,960.29	$28,325	$237.94	+$12.06M → BVXV
10	$22,598,667	$9,667,205.19	$31,624	$239.96	+$22.57M → BVXV

BVXV vs DGRO: Complete Analysis 2026

BVXV — Stock

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Full BVXV Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →

📬

Get this BVXV vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVXV vs SCHD BVXV vs JEPI BVXV vs O BVXV vs KO BVXV vs MAIN BVXV vs VIG BVXV vs NOBL BVXV vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.